| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2022 ( Subtotal = $42,282,546 ) (Continued on the next page) |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 001 | 22 | NIH | 5/9/2022 | $3,559,286 |
| 2022 | 2022 | UNIVERSITY OF IOWA, THE | 105 JESSUP HALL | IOWA CITY | IA | 52242-1316 | JOHNSON | USA | R01CA180986 | E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function | 002 | 8 | NIH | 12/29/2021 | $312,862 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P50AA024337 | The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ Injury | 002 | 7 | NIH | 5/21/2022 | $1,467,472 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15ES028440 | Prenatal Cigarette Smoke Exposure: Impact on Offspring Gut Bacterial Microbiome | 000 | 2 | NIH | 6/17/2022 | $469,458 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE026963 | P. gingivalis genes essential for tobacco smoke survival | 000 | 5 | NIH | 6/9/2022 | $367,971 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | T35EY026509 | Summer Vision Sciences Training Program | 000 | 6 | NIH | 5/27/2022 | $15,020 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31DE027585 | Exploitation of the host immune response by Aggregatibacter actinomycetemcomitans mediated by QseBC | 000 | 5 | NIH | 12/29/2021 | $33,288 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31DE027585 | Exploitation of the host immune response by Aggregatibacter actinomycetemcomitans mediated by QseBC | 001 | 5 | NIH | 4/28/2022 | $717 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31DE027585 | Exploitation of the host immune response by Aggregatibacter actinomycetemcomitans mediated by QseBC | 002 | 5 | NIH | 5/25/2022 | -$1 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS100996 | Modulating Inhibitory Action Control Systems With Subthalamic Nucleus Stimulation | 000 | 5 | NIH | 1/31/2022 | $293,333 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES029846 | Diversity Supplement to Urban Greenness and Cardiovascular Health | 001 | 5 | NIH | 3/30/2022 | $151,287 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES029846 | Diversity Supplement to Urban Greenness and Cardiovascular Health | 000 | 5 | NIH | 3/29/2022 | $616,735 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS108529 | The integrated stress response and oligodendrocyte survival after spinal cord injury | 000 | 5 | NIH | 3/31/2022 | $534,051 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01GM127495 | Exercise-enhanced resolution of inflammation | 000 | 5 | NIH | 5/9/2022 | $462,462 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL141081 | The Role of Cardiomyogenic Lineage Commitment in Cardiac Mesenchymal Cell-Mediated Extracellular Vesicle Signaling and Cardiac Repair | 000 | 5 | NIH | 2/22/2022 | $346,500 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK116591 | miRNA Mechanism of Acute Kidney Injury in Aging | 000 | 4 | NIH | 5/27/2022 | $531,474 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL142710 | Regulation of Coronary Blood Flow | 000 | 5 | NIH | 6/13/2022 | $620,827 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM125504 | Functional Microbiomics, Inflammation and Pathogenicity | 001 | 5 | NIH | 2/24/2022 | $1,922,090 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM125504 | Functional Microbiomics, Inflammation and Pathogenicity | 002 | 5 | NIH | 5/17/2022 | $213,570 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES028268 | Effects of Air Pollution on Stem Cell Health | 000 | 5 | NIH | 5/16/2022 | $421,187 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U01AA026980 | Alcoholic Hepatitis Network 3/9 University of Louisville | 000 | 5 | NIH | 6/14/2022 | $349,588 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS110169 | Regulation of swallow and the effects of high cervical spinal cord injury | 001 | 4 | NIH | 3/28/2022 | $33,688 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS110169 | Regulation of swallow and the effects of high cervical spinal cord injury | 000 | 4 | NIH | 12/1/2021 | $303,187 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK115406 | CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis | 000 | 5 | NIH | 4/4/2022 | $390,621 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AG061065 | Role of Gut Microbial Dysbiosis and Aging on HIV-associated neurocognitive and brain dysfunction | 000 | 5 | NIH | 4/29/2022 | $742,372 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U01AA026936 | Lipid metabolites can both potentiate and treat alcoholic hepatitis | 000 | 5 | NIH | 6/15/2022 | $232,206 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DC007176 | Regulation of taste neuron morphology and function | 001 | 17 | NIH | 2/22/2022 | $449,691 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H79TI082725 | Integrated Care for Persons with Co-Occurring Disorders | 000 | 3 | SAMHSA | 4/15/2022 | $398,741 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K08DK123381 | Interaction of the Microtubule Cytoskeleton and Perilipin-2 Regulates Hepatic Lipid Droplets - a Potential Therapeutic Target for Fatty Liver Disease | 000 | 2 | NIH | 3/23/2022 | $165,780 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE028883 | Topical Vitamin D and Periodontal Disease | 001 | 2 | NIH | 4/21/2022 | $49,276 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE028883 | Topical Vitamin D and Periodontal Disease | 000 | 2 | NIH | 3/31/2022 | $492,732 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F32AA027950 | RvD1-FPR2 signaling ameliorates alcoholic liver disease | 001 | 3 | NIH | 5/27/2022 | $1,757 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F32AA027950 | RvD1-FPR2 signaling ameliorates alcoholic liver disease | 000 | 3 | NIH | 5/5/2022 | $46,440 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL147921 | Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure | 001 | 3 | NIH | 5/31/2022 | $76,960 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL147921 | Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure | 000 | 3 | NIH | 3/17/2022 | $692,604 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F32HL149140 | Deciphering the Relationship Between Cardiomyocyte Metabolic Configuration and Cell Cycle Re-entry | 000 | 2 | NIH | 12/31/2021 | $79,642 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI153275 | Comprehensive Definition of the Critical Role(s) of the Alphaviral Noncapped Genomic RNAs to Infection and Pathogenesis | 000 | 3 | NIH | 4/15/2022 | $385,979 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U18TR003787 | A Handheld Microchip for GC analysis of breath to screen for COVID-19 | 003 | 2 | NIH | 5/24/2022 | $0 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U18TR003787 | A Handheld Microchip for GC analysis of breath to screen for COVID-19 | 001 | 2 | NIH | 2/14/2022 | $957,641 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY031322 | Parallel Pulvinar Pathways | 000 | 3 | NIH | 5/12/2022 | $477,112 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K01MH119942 | Examining HIV-related Stigma and HIV Testing Among Formerly Incarcerated African American Youth | 000 | 3 | NIH | 4/22/2022 | $160,013 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK123712 | Preclinical validation of oral therapeutic lead proteins targeting epithelial GM1 ganglioside for ulcerative colitis therapy | 000 | 3 | NIH | 3/24/2022 | $443,196 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DC018273 | Neural mechanisms underlying integration of taste and smell | 000 | 3 | NIH | 6/8/2022 | $328,252 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK124112 | The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease. | 001 | 3 | NIH | 3/31/2022 | $50,237 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK124112 | The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease. | 000 | 3 | NIH | 12/17/2021 | $452,125 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R37CA234002 | Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors | 000 | 3 | NIH | 6/20/2022 | $356,850 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY030933 | Blood outer retina barrier regulation | 000 | 3 | NIH | 2/3/2022 | $577,354 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL149351 | Atherogenic Mechanisms of Electronic Nicotine Delivery Systems | 001 | 3 | NIH | 6/13/2022 | $71,909 |
| 2022 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL149351 | Atherogenic Mechanisms of Electronic Nicotine Delivery Systems | 000 | 3 | NIH | 12/2/2021 | $647,176 |
|